Trained immunity in inflammatory bone disease: a bibliometric and literature-level text-mining analysis

• by Zihang Zhao, Zihan Liu, Liang Guo, Teng Pan, Ruoyu Wang, Yiran Li, Yingchao Yin, Ruipeng Zhang, Zhiyong Hou

• May 20, 2026

Correction: Lubricin in osteoarthritis: functions and therapeutic prospects

• by Haochen Li, Guoliang Yi, Dan Zhou, Jiayi Zhou, Zhi Cui, Haowei Zhang, Zhiwei Chen

• August 21, 2026

Integrated post-GWAS, single-cell, and functional analyses prioritize TCTN2 at an osteoarthritis locus associated with innate immunity-related cartilage remodeling

• by Changchun Lu, Lei Wang, Xinqi Cao, Kun Zhao, Nuo Yin, Dong Zhang

• July 6, 2026

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

• by Andrea Surnit

• June 5, 2026

• 7 min